Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Pfizer”
- Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)Active Not Recruiting
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetes Mellitus, Type 1
United States, Australia, Canada
Sponsor: QuantumLeap Healthcare Collaborative
HER2-positive Breast Cancer · Metastatic Cancer · Metastatic Breast Cancer · Metastatic
United States
Sponsor: American Society of Clinical Oncology
Lymphoma, Non-Hodgkin · Multiple Myeloma · Advanced Solid Tumors
United States, Puerto Rico
- A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsActive Not Recruiting
Sponsor: Pfizer
Melanoma · Glioma · Thyroid Cancer · Non-Small Cell Lung Cancer
United States, Australia, Brazil, Canada, China +2 more
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.Active Not Recruiting
Sponsor: Pfizer
Melanoma · Non-Small-Cell Lung Cancer · Thyroid Cancer · Glioma
United States, Canada, Israel
- A Study of COVID-19 Vaccine(s) in Children and AdultsNot Yet Recruiting
Sponsor: BioNTech SE
COVID-19 Vaccines
- A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.Active Not Recruiting
Sponsor: Pfizer
Hidradenitis Suppurativa
United States, Canada, Germany, Greece, Poland +1 more
Sponsor: Icahn School of Medicine at Mount Sinai
Keloid
United States
Sponsor: Massachusetts General Hospital
Transthyretin Amyloidosis · Heart Failure · Heart Failure, Diastolic · Amyloidosis
United States
Sponsor: Inova Health Care Services
Sickle Cell Disease
United States
Sponsor: Pfizer
Moderate to Severe Chronic Obstructive Pulmonary Disease
United States, Argentina, Canada, China, Czechia +5 more
Sponsor: Pfizer
Healthy Adults
Japan
- Elranatamab in R/R Multiple MyelomaRecruiting
Sponsor: Massachusetts General Hospital
Refractory Multiple Myeloma · Relapse Multiple Myeloma · Multiple Myeloma
United States
Sponsor: Pfizer
Pneumococcal Disease
United States, Puerto Rico
Sponsor: University of Calgary
Growth Hormone Deficiency · Traumatic Brain Injury
Canada
- A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to AdultsNot Yet Recruiting
Sponsor: Pfizer
Pneumococcal Disease
United States
- Safety and Efficacy of Xalkori ROS1Completed
Sponsor: Pfizer
Non-small Cell Lung Cancer
Japan
- A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune DiseasesNot Yet Recruiting
Sponsor: Pfizer
Systemic Lupus Erythematosus · Rheumatoid Arthritis · Idiopathic Inflammatory Myositis · Systemic Sclerosis
Sponsor: Pfizer
Obesity · Overweight or Obesity
United States
- Tucatinib Continuation StudyNot Yet Recruiting
Sponsor: Pfizer
HER2-positive Breast Cancer · Cervical Cancer · Biliary Tract Neoplasms · Urothelial Cancer
- A Study to Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Japan.Active Not Recruiting
Sponsor: Pfizer
Hemophilia A or B
Japan
Sponsor: Pfizer
ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
South Korea
- Litfulo Capsules Special InvestigationActive Not Recruiting
Sponsor: Pfizer
Alopecia Areata
Japan
- Lorlatinib Continuation StudyActive Not Recruiting
Sponsor: Pfizer
Non-Small-Cell Lung Cancer · NSCLC
United States, China, France, India, Japan +3 more
Sponsor: ETOP IBCSG Partners Foundation
Breast Cancer · Estrogen Receptor Positive Tumor · HER2-positive Breast Cancer
Belgium, France, Italy, Switzerland